Could ventilator-associated pneumonia be a design issue?:
This article was originally published in Clinica
Plans to launch research into the care of ventilator-associated pneumonia (VAP) suggests there is room for manufacturers to address the problem from an equipment design perspective. The University of Edinburgh is launching next month a five-year study of ways to fight antibiotic-resistant VAP. It is estimated that as many as 20% of patients who require treatment on a ventilator machine may develop VAP and the infection is fatal in a high proportion of cases.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.